Key facts
- Notable investors include Oita Venture Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Happy Cat Dog
- ·The full record, as it builds
Funding rounds
No funding rounds for Happy Cat Dog are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Happy Cat Dog
Developer of veterinary pharmaceutical therapies intended to prevent and treat severe feline infectious diseases. The company utilizes a drug discovery research platform built in collaboration with universities and research institutes, applies human-level pharmaceutical R&D methodologies to companion animal medicine, and coordinates cross-functional teams spanning research, clinical development, enabling veterinarians and pet owners to access evidence-based treatment options for feline coronavirus and feline infectious peritonitis.
- Sector
- Healthcare
- HQ
- Oita, Japan
- Website
- happy-cat-dog.com/
- Ownership
- Privately Held (backing)
Happy Cat Dog doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Happy Cat Dog shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Happy Cat Dog in its N-PORT filings yet. We sweep new filings monthly.